Fig. 4From: First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cellsPatient #21: tumor regression of patient’s poorly differentiated squamous cell carcinoma (Stage: IV_B)Back to article page